DRB436X
Drug
Novartis Pharma AG
Total Payments
$12,960
Transactions
1
Doctors
1
Companies
1
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2017 | $12,960 | 1 | 1 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $12,960 | 1 | 100.0% |
Top Doctors Receiving Payments for DRB436X
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| , MD | Hematology & Oncology | Philadelphia, PA | $12,960 | 1 |
Ad
Manufacturing Companies
- Novartis Pharma AG $12,960
Product Information
- Type Drug
- Total Payments $12,960
- Total Doctors 1
- Transactions 1
About DRB436X
DRB436X is a drug associated with $12,960 in payments to 1 healthcare providers, recorded across 1 transactions in the CMS Open Payments database. The primary manufacturer is Novartis Pharma AG.
Payment data is available from 2017 to 2017. In 2017, $12,960 was paid across 1 transactions to 1 doctors.
The most common payment nature for DRB436X is "Consulting Fee" ($12,960, 100.0% of total).